CClinicalTrials.gg
CompletedNCT02197013Updated Aug 3, 2023

Evaluation of Introcan Safety 3 Closed IV Catheter

An observational study in Patients in Need for Intravenous Access, sponsored by B. Braun Melsungen AG. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2023-08-03.

Sponsored by B. Braun Melsungen AG · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Sex
All
01

Study summary

Incidence and time of occurrence of blood leakage with the closed intravascular catheter Introcan Safety 3 in comparison to Introcan Safety

02

Conditions studied

  • Patients in Need for Intravenous Access
03

In context

Lead sponsor

B. Braun Melsungen AG is the lead sponsor of 46 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in need for intravenous access

Inclusion criteria

  • need for intravenous access

Exclusion criteria

Exclusion Criteria:

  • n. a.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No

Groups and cohorts

  • Introcan Safety 3

    Closed IV Catheter

  • Introcan Safety

    IV catheter

06

What researchers measure

Primary outcomes

  1. Frequency and time of occurence of blood leakage

    Time frame: Within one minute

Secondary outcomes

  1. Problems during catheter insertion and fixation of Introcan Safety 3

    Time frame: During insertion and fixation of catheter

  2. Necessity of disconnection of catheter

    Time frame: During catheter placement

07

Study locations

1 site
  • KKRN Katholisches Klinikum Ruhrgebiet Nord GmbH (KKRN)
    Dorsten, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02197013
Lead sponsor
B. Braun Melsungen AG
Responsible party
Sponsor
First posted
Jul 22, 2014
Start date
Sep 2012
Primary completion
Oct 2012
Completion
Oct 2012
Last update
Aug 3, 2023

Study contacts

Gertrud Haeseler, Prof.
principal investigator · KKRN

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion